Class information for: |
Basic class information |
ID | Publications | Average number of references |
Avg. shr. active ref. in WoS |
---|---|---|---|
25361 | 235 | 27.3 | 41% |
Classes in level above (level 2) |
Terms with highest relevance score |
Rank | Term | Type of term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|---|
1 | WHOLE BLOOD CELL CULTURES | Author keyword | 2 | 40% | 2% | 4 |
2 | COLORIMETRY METHOD | Author keyword | 1 | 50% | 0% | 1 |
3 | HUMAN COLORECTAL TUMORS | Author keyword | 1 | 50% | 0% | 1 |
4 | INHALATIONBIOL | Address | 1 | 50% | 0% | 1 |
5 | CATTLE MALE REPRODUCTION | Author keyword | 0 | 33% | 0% | 1 |
6 | CELL CULTURE METHODOLOGY | Author keyword | 0 | 33% | 0% | 1 |
7 | PORCINE SPERMATOZOA | Author keyword | 0 | 33% | 0% | 1 |
8 | TH1 TH2 CYTOKINE RESPONSE | Author keyword | 0 | 33% | 0% | 1 |
9 | TUMOUR MARKERS | Address | 0 | 33% | 0% | 1 |
10 | CYTOKINE IMBALANCE | Author keyword | 0 | 20% | 0% | 1 |
Web of Science journal categories |
Author Key Words |
Key Words Plus |
Rank | Web of Science journal category | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | TUMOR CANCER PATIENTS | 2 | 67% | 1% | 2 |
2 | I II TRIALS | 1 | 50% | 0% | 1 |
3 | PHOSPHATASE ANTIBODY CONJUGATE | 1 | 50% | 0% | 1 |
4 | FC RECEPTOR EXPRESSION | 0 | 33% | 0% | 1 |
5 | IMMATURE PROGENITORS | 0 | 33% | 0% | 1 |
6 | IMMUNOLOGICAL DYSFUNCTION | 0 | 20% | 0% | 1 |
7 | SERUM CYTOKINE | 0 | 20% | 0% | 1 |
8 | MYCOBACTERIUM VACCAE SRL172 | 0 | 10% | 0% | 1 |
9 | PHYTOHEMAGGLUTININ INDUCED PROLIFERATION | 0 | 100% | 0% | 1 |
10 | PROGRESSIVE TUMOR GROWTH | 0 | 100% | 0% | 1 |
Journals |
Reviews |
Title | Publ. year | Cit. | Active references | % act. ref. to same field |
---|---|---|---|---|
SUPPRESSOR-CELL FUNCTION IN SOLID TUMOR-CANCER PATIENTS | 1987 | 27 | 42 | 40% |
SERIAL IMMUNE FUNCTION TESTING TO PREDICT CLINICAL-DISEASE RELAPSE IN PATIENTS WITH SOLID TUMORS | 1983 | 10 | 7 | 71% |
BIOLOGICAL AND IMMUNOLOGICAL ROLES OF PROTEINS IN THE SPERM OF DOMESTIC-ANIMALS (REVIEW) | 1985 | 11 | 46 | 20% |
ASSAYS OF IMMUNOCOMPETENCE IN THE STAGING AND PROGNOSIS OF CANCER | 1981 | 9 | 2 | 100% |
VISTAS IN THE USE OF NONSTEROID ANTIINFLAMMATORY DRUGS FOR CANCER-TREATMENT | 1990 | 0 | 30 | 10% |
IMMUNOTHERAPY OF PROSTATE-CANCER | 1993 | 1 | 61 | 7% |
Advances in immunotherapy for prostate cancer | 2003 | 4 | 138 | 2% |
HEMATOLOGY - AN ANNOTATED-BIBLIOGRAPHY OF RECENT LITERATURE - REFERENCES TO JOURNAL ARTICLES AND OTHER PAPERS | 1982 | 0 | 60 | 3% |
Address terms |
Rank | Address term | Relevance score (tfidf) |
Class's shr. of term's tot. occurrences |
Shr. of publ. in class containing term |
Num. of publ. in class |
---|---|---|---|---|---|
1 | INHALATIONBIOL | 1 | 50% | 0.4% | 1 |
2 | TUMOUR MARKERS | 0 | 33% | 0.4% | 1 |
3 | ENVIRONM HLTH ASKLEPIOS HKLIN | 0 | 100% | 0.4% | 1 |
4 | HEMATOPOIET STEM CELL TRANSPLANT SECT | 0 | 100% | 0.4% | 1 |
5 | MED HLTH COMMUNITY | 0 | 100% | 0.4% | 1 |
Related classes at same level (level 1) |
Rank | Relatedness score | Related classes |
---|---|---|
1 | 0.0000274063 | BOVINE BETALACTOGLOBULIN//MUCOSAL ANTIGENS//BR AMBEDKAR ROTARY CANC HOSP |
2 | 0.0000195437 | IG LEVELS//LEUKEMIC CHILDREN//PROGNOSIS SURVIVAL |
3 | 0.0000159876 | IMMUNE SUPPRESSOR CELLS//IRX 2//SERV 151Z2 |
4 | 0.0000132064 | POSTOPERATIVE SEPTIC COMPLICATIONS//BRIAN MIND//LOOSENING OF ENDOPROSTHESES |
5 | 0.0000119048 | CD3 ZETA//ORAL BIOL ORAL MED//ZETA CHAIN |
6 | 0.0000105316 | 2HB ANTIGEN//CIENCIAS BIOQUIM ARTADO 644//DELAYED HYPERSENSITIVITY SKIN TEST |
7 | 0.0000102549 | CAS 15687 21 1//15 HYDROXY EICOSATETRAENOIC ACID//15 OH PROSTAGLANDIN DEHYDROGENASE |
8 | 0.0000099475 | PHOSPHOENOL PYRUVIC ACID//// |
9 | 0.0000097979 | P15E//CKS 17//ADV MED TREATMENTS |
10 | 0.0000096895 | DITHIONITROBENZOATE//IGG BLOOD//YOSHIDA HEPATOMA |